FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2022
Back to search
Official data from USPTO
REGULGENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REGULGENT
ST13
US500000079316567Class
5, 40, 42
Filing
79316567
Registration
6816928
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/21/2022
Trademark type
Word
Nice classes
5, 40, 42
Filing date
05/26/2021
Registration date
08/16/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
08/16/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kyowa Kirin Co., Ltd.
Representatives
Kaushal Odedra ODEDRA LAW OFFICE, PLLC
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals comprising monospecificbispecific or multispecific antibodiesfragments of monospecificbispecific or multispecific antibodies and derivatives of monospecificbispecific or multispecific antibodies for medical purposes; cells for medical usecells that manufacture antibodiesfragments of antibodies and derivatives of antibodies for medical purposes; cells for medical purposes
Class 40
Contract manufacturing service in the field of antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of pharmaceuticals comprising antibodiesfragments of antibodies and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies; Custom manufacturingcontractrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; providing information in the field of custom manufacturing in the field of antibodiesfragments of antibodies and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodiesfragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of pharmaceuticals comprising antibodiesfragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of pharmaceuticals comprising antibodiesfragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies; providing technical information in the field of contract manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; technical consultation in the field of manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals
Class 42
Development of antibodiesfragments of antibodies and derivatives of antibodies for others; development of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies for others; development of host cells for others; providing technical information in the field of development of antibodiesfragments of antibodies and derivatives of antibodies; providing technical information in the field of development of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies; technical consultation in the field of development of antibodiesfragments of antibodies and derivatives of antibodies; technical consultation in the field of development of cells that manufacture antibodiesfragments of antibodies and derivatives of antibodies
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/26/2022
FIMP
FINAL DISPOSITION PROCESSED
11/26/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/16/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/23/2022
RFNT
REFUSAL PROCESSED BY IB
04/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/18/2022
RFRR
REFUSAL PROCESSED BY MPU
03/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/17/2022
CNRT
NON-FINAL ACTION WRITTEN
02/16/2022
DOCK
ASSIGNED TO EXAMINER
02/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens REGULGENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.